Community pharmacists optimising treatment for patients with psoriasis

Is it feasible for community pharmacists to deliver an educational programme designed to help people with psoriasis self-manage as effectively as possible?

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN67700775

Enrollment

Registered

2014-05-22

Start date

2014-07-30

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Primary Care

Interventions

The pharmacists will opportunistically approach patients who present with prescriptions for themselves for psoriasis. Eligible patients who agree to participate will be asked to complete the SAPASI an

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients aged over 18 with a diagnosis of chronic plaque psoriasis currently prescribed topical treatment 2. Male & Female 3. Lower Age Limit: 18 no age limit or unit specified

Exclusion criteria

Exclusion criteria: Patients under 18 years, prescribed oral therapy or receiving phototherapy

Design outcomes

Secondary

Measure	Time frame
Dermatology quality of life index (DLQI); Timepoint(s): 6 weeks, at the follow-up appointment; sapasi; Timepoint(s): 6 weeks, at follow-up appointment	—

Primary

Measure	Time frame
Pedesi; Timepoint(s): at follow-up after 6 weeks	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026